GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Net Income (Continuing Operations)

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Net Income (Continuing Operations) : ¥-200.4 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Hebei Changshan Biochemical Pharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ¥1.6 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-200.4 Mil.

Hebei Changshan Biochemical Pharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co Net Income (Continuing Operations) Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 251.14 231.26 10.16 -1,248.15 -264.03

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -62.01 15.10 19.10 -236.23 1.63

Hebei Changshan Biochemical Pharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-200.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hebei Changshan Biochemical Pharmaceutical Co  (SZSE:300255) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Hebei Changshan Biochemical Pharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Net Income (Continuing Operations)
Comparable Companies
SHSE:688266 SZSE:301301 SZSE:002007 SZSE:002821 SHSE:688278 SHSE:603233 SHSE:688166 SHSE:688336 SHSE:688520 SZSE:000403 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800
Website
http://www.hbcsbio.com
Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.
Executives
Li Zhi Hua Executives
Wang Jun Executives
Ding Jian Wen Directors, executives
Huang Guo Sheng Executives
Gao Shu Hua Directors, executives
Chen Xi Director
Cai Hao Executives
Ji Sheng Li Directors, executives
Li Xin Securities Affairs Representative
Zhang Wei Secretary Dong
Liu Jian Executives
Zhang Zhi Ying Executives
Guo Yan Xing Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines